For research use only. Not for therapeutic Use.
Fusidic Acid-d6 is a deuterated form of fusidic acid, featuring six deuterium atoms. This isotopically labeled compound is particularly valuable in pharmaceutical research, especially for studying the metabolism, pharmacokinetics, and mechanism of action of fusidic acid, an antibiotic commonly used to treat bacterial infections. The deuterium labeling enhances the precision of mass spectrometric analyses, allowing for accurate tracking and quantification of fusidic acid in biological samples. Fusidic Acid-d6 is essential for investigating drug interactions, optimizing dosing regimens, and developing new antibiotic therapies. Its high purity and stability ensure reliable and consistent results in advanced research applications, making it a crucial tool for scientists focused on antibiotic development and bacterial resistance studies.
Catalog Number | R009195 |
CAS Number | NA |
Synonyms | (3α,4α,8α,9β,11α,13α,147β,167β,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic Acid-d6; Flucidin-d6; Fucithalmic-d6; Fusidinic Acid-d6; NSC 56192-d6; Ramycin-d6; SQ 16603-d6; |
Molecular Formula | C₃₁H₄₂D₆O₆ |
Purity | ≥95% |
Storage | Store at -20°C |
IUPAC Name | (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-7,7,7-trideuterio-6-(trideuteriomethyl)hept-5-enoic acid |
InChI | InChI=1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20-/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-/m0/s1/i1D3,2D3 |
InChIKey | IECPWNUMDGFDKC-CUNJLYJJSA-N |
SMILES | [2H]C([2H])([2H])C(=CCC/C(=C/1\[C@@H]2C[C@H]([C@H]3[C@]4(CC[C@H]([C@H]([C@@H]4CC[C@@]3([C@]2(C[C@@H]1OC(=O)C)C)C)C)O)C)O)/C(=O)O)C([2H])([2H])[2H] |